BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Sun Pharmaceutical Industries Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524715
ISIN Demat
INE044A01036
Book Value (Rs)
99.2482659
NSE Symbol
SUNPHARMA
Divident Yield %
0.93
Market Cap
(Rs In Cr.)
412,626
P/E (TTM)
88.28
EPS (TTM)
19.48
Face Value
(Rs)
1
Back
Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter
05-Nov-25   Hrs IST

Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales14405.2213264.22 9
OPM %31.4329.70 -
PBDT4897.114223.79 16
PBT4167.613597.88 16
NP3117.953040.16 3

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)